Evidence map›Paper›PMID 28367587›Full record

ArticleIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2017

Radiofrequency ablation for gastric antral vascular ectasia and radiation proctitis.

Pave Markos, Branko Bilic, Hrvoje Ivekovic, Nadan Rustemovic

Abstract read
PubMed Publisher
In one paragraph

Article in Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Endoscopic treatment for gastric antral vascular ectasia.Therapeutic advances in chronic disease · 2021
    Review
  8. Gastrointestinal Manifestations of Systemic Sclerosis.Rheumatology (Sunnyvale, Calif.) · 2018
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pave MarkosDepartment of Gastroenterology and Hepatology, Endoscopy Unit, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia. pave.markos@gmail.com.
Branko BilicDepartment of Gastroenterology and Hepatology, Endoscopy Unit, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.
Hrvoje IvekovicDepartment of Gastroenterology and Hepatology, Endoscopy Unit, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.
Nadan RustemovicDepartment of Gastroenterology and Hepatology, Endoscopy Unit, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.
University Hospital Centre Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric antral vascular ectasia (GAVE) and chronic radiation proctitis (CRP) are well-known causes of repeated gastrointestinal bleeding and iron deficiency anemia. Argon plasma coagulation (APC) is the most common endoscopic therapy used, but some patients need multiple APC sessions. Radiofrequency ablation (RFA) is recently used in GAVE and CRP treatment with promising results. In this case series, we analyzed data for 15 patients with GAVE and 5 patients with CRP that had multiple prior APC treatment. They were treated with RFA HALO 90 catheter (HALO90 Ablation Catheter System; Covidien, GI Solutions, Sunnyvale, CA) in our tertiary referral center. A total of 20 patients received 32 RFA procedures (8 in the CRP group and 24 in the GAVE group). The median number of the procedures was 2 (range 1-4). The hemoglobin levels in the GAVE group were 83 g/L pre-RFA and 98 g/L post-RFA and in the CRP group, 86 g/L pre-RFA and 103 g/L post-RFA. A total of 16/20 patients (80%) were transfusion-free after the completion of RFA treatment. Technical success of the treatment was 95% (19/20 patients). RFA can be safely and successfully used in APC refractory GAVE and CRP patients.

Indexed as

AgedAged, 80 and overAnemia, Iron-DeficiencyCatheter AblationChronic DiseaseFemaleGastric Antral Vascular EctasiaGastrointestinal HemorrhageHumansMaleProctitisRadiotherapyTreatment OutcomeArgon plasma coagulationChronic radiation proctitisGastric antral vascular ectasiaGastrointestinal bleedingRadiofrequency ablation

Identifiers

PMID28367587
OpenAlexW2601351508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.